These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Male BRCA1 and BRCA2 mutation carriers: a pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinic. Horsburgh S; Matthew A; Bristow R; Trachtenberg J Prostate; 2005 Oct; 65(2):124-9. PubMed ID: 15880530 [TBL] [Abstract][Full Text] [Related]
27. How to use PSA to screen for prostate cancer. Little B; Young M Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941 [TBL] [Abstract][Full Text] [Related]
28. Prostate cancer screening: what have we learned? Zaragoza MR Del Med J; 1999 Jul; 71(7):301-2. PubMed ID: 10457667 [No Abstract] [Full Text] [Related]
29. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history. McDowell ME; Occhipinti S; Gardiner RA; Chambers SK BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497 [TBL] [Abstract][Full Text] [Related]
30. Early detection of prostate cancer. Role of prostate-specific antigen. Prabhakaran VM Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039 [TBL] [Abstract][Full Text] [Related]
31. Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families. Matikainen MP; Schleutker J; Mörsky P; Kallioniemi OP; Tammela TL Clin Cancer Res; 1999 Jun; 5(6):1275-9. PubMed ID: 10389909 [TBL] [Abstract][Full Text] [Related]
32. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761 [No Abstract] [Full Text] [Related]
33. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Moyer VA; Ann Intern Med; 2012 Jul; 157(2):120-34. PubMed ID: 22801674 [TBL] [Abstract][Full Text] [Related]
34. Prostate cancer screening: what we know, don't know, and believe. Brawley OW Ann Intern Med; 2012 Jul; 157(2):135-6. PubMed ID: 22801675 [No Abstract] [Full Text] [Related]
35. PSA testing in general practice. Little B; Ho KJ; Gormley G; Young M Prostate Cancer Prostatic Dis; 2003; 6(2):154-8. PubMed ID: 12806375 [TBL] [Abstract][Full Text] [Related]
36. Prostate cancer screening: the need for problem-solving that puts men's interests first. Holmberg L Eur Urol; 2009 Jul; 56(1):34-7. PubMed ID: 19394132 [No Abstract] [Full Text] [Related]
37. The role of the prostate cancer antigen 3 (PCA3) test for the diagnosis of prostate cancer in the era of opportunistic prostate-specific antigen screening. Ficarra V; Novara G; Zattoni F Eur Urol; 2010 Oct; 58(4):482-4; discussion 484-5. PubMed ID: 20685032 [No Abstract] [Full Text] [Related]
38. [Characterisation of families with hereditary prostate cancer in the Netherlands]. Meulenbeld HJ; Verhage BA; Kil PJ; Kiemeney LA; Vasen HF Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1938-42. PubMed ID: 12404910 [TBL] [Abstract][Full Text] [Related]
39. Does early detection of prostate cancer offer more good than harm? Feightner JW Can J Oncol; 1994 Nov; 4 Suppl 1():74-5. PubMed ID: 8853495 [No Abstract] [Full Text] [Related]
40. Development and pilot testing of an online screening decision aid for men with a family history of prostate cancer. Wakefield CE; Watts KJ; Meiser B; Sansom-Daly U; Barratt A; Mann GJ; Lobb EA; Gaff CL; Howard K; Patel MI Patient Educ Couns; 2011 Apr; 83(1):64-72. PubMed ID: 20580521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]